Evidence map›Paper›PMID 39150067›Full record

ArticleJournal of addiction medicine

Induction to Methadone 80 mg in the First Week of Treatment of Patients Who Use Fentanyl: A Case Series From an Outpatient Opioid Treatment Program.

Scott Steiger, Caravella McCuistian, Leslie W Suen, Brad Shapiro, D Andrew Tompkins, Alexander R Bazazi

Abstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Scott SteigerFrom the Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, Department of Medicine, University of California San Francisco, San Francisco, CA (SS, LWS); and Division of Substance Abuse and Addiction Medicine at Zuckerberg San Francisco General Hospital, Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA (SS, CMC, BS, DAT, ARB).ORCID 0000-0002-3761-479
Caravella McCuistian
Leslie W Suen
Brad Shapiro
D Andrew Tompkins
Alexander R Bazazi

Funding

UCSF Learning Health System K12 Career Development ProgramK12HS026383 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GONZALES, RALPH, SARKAR, URMIMALA · 2018 to 2022
$3.6M
Development of a Technology-Based HIV Prevention Intervention for Black Women Who Use SubstancesK23DA060073 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Caravella McCuistian · 2024 to 2026
$569k
The Effect of Chronic Pain on Delay Discounting in Methadone PatientsR21DA047520 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TOMPKINS, DAVID ANDREW · 2019 to 2020
$460k
AHRQ HHS K12 HS026383NIDA NIH HHS K23 DA060073NIDA NIH HHS R21 DA047520
6 · The paper itself

Abstract

objectivesCurrent guidelines for methadone titration may unnecessarily delay reaching effective doses for patients using fentanyl, resulting in an increased risk of ongoing fentanyl use, dissatisfaction with treatment, and early dropout. Development and evaluation of rapid methadone induction protocols may improve treatment for patients using fentanyl.

methodsRetrospective chart review was conducted for patients admitted in 2022 to a single licensed opioid treatment program (OTP) where a rapid induction protocol provides methadone 40 mg on day 1, 60 mg on day 2, and 80 mg on day 3 to patients using fentanyl <65 years old without significant medical comorbidities. The primary feasibility outcome was completion of the protocol, defined by receipt of methadone dose 80 mg or more on treatment day 7. The primary safety outcomes were oversedation, nonfatal overdose, and death. A secondary outcome was retention in treatment at 30 days.

resultsRapid induction was ordered for 93 patients and completed by 65 (70%). Average dose on day 7 for patients who completed was 89 mg (SD 9.5 mg) versus 49 mg (SD 14.0 mg) for those who did not. No episodes of oversedation, nonfatal overdose, or death were observed. At 30 days, 85% of the patients who had the rapid protocol ordered (79/93) were retained, with 88% (57/65) who completed the protocol retained versus 79% (22/28) who did not complete (OR 1.9, 95% CI 0.6-6.2).

conclusionsRapid induction to methadone 80 mg by day 7 was feasible for outpatients using fentanyl in this study at a single OTP. No significant safety events were identified.

Indexed as

FentanylMethadoneOpiate Substitution TreatmentOpioid-Related DisordersAdultAnalgesics, OpioidFemaleHumansMaleMiddle AgedRetrospective StudiesAnalgesics, OpioidFentanylMethadone

Identifiers

PMID39150067
PMCPMC11446640

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.